<DOC>
	<DOCNO>NCT02986594</DOCNO>
	<brief_summary>In clinical cohort study , investigator observe efficacy low molecular weight heparin treatment thrombophilia recurrent pregnancy loss prospective randomize controlled trial .</brief_summary>
	<brief_title>Diagnosis Treatment Strategy Recurrent Spontaneous Abortion Associated With Thrombophilla</brief_title>
	<detailed_description />
	<mesh_term>Thrombophilia</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<criteria>Woman Second miscarriage 12 ( th ) week gestation.The patient diagnose thrombophilia recurrent pregnancy loss . Signed consent form . 1. experiencedsevere allergy , trauma history and/or operation history within 3 month 2. history mental illness and/or family history mental illness 3. limb disable 4. take medicine within one month 5. suffer major event mood swing 6. history recurrent pregnancy loss 7. internal surgical disease ( variety physical examination electrocardiogram/hepatic renal function/blood routine urine rotine ) 8 . Chromosome aberration anyone couple . 9. patient drug contraindication</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>